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ABSTRACT Photoreactivating enzyme (DNA photolyase;
deoxyribocyclobutadipyrimidine pyrimidine-lyase, EC
4.1.99.3) repairs UV damage to DNA by utilizing the energy of
near-UV/visible light to split pyrimidine dimers into mono-
mers. The enzyme is widespread in nature but is absent in
certain species in a seemingly unpredictable manner. Its pres-
ence in humans has been a source of considerable controversy.
To help resolve the issue we used a very specific and sensitive
assay to compare photoreactivation activity in human, rattle-
snake, yeast, and Escherichia coli cells. Photolyase was easily
detectable in E. coli, yeast, and rattlesnake cell-free extracts
but none was detected in cell-free extracts from HeLa cells or
human white blood cells with an assay capable of detecting 10
molecules per cell. We conclude that humans most likely do not
have DNA photolyase.
Pyrimidine dimers (YOY) are one of the major DNA photo-
products induced by solar irradiation of biological systems.
These lesions can be eliminated from DNA by photoreacti-
vation or excision repair (1). Excision repair has been found
in all species tested. In contrast, photoreactivation (splitting
of YOY by an enzyme called DNA photolyase) is not
universal, and its distribution among various species, super-
ficially at least, does not make teleological sense. Thus, the
enteric bacterium Escherichia coli is photoreactivable but the
soil bacterium Bacillus subtilis is not; the budding yeast
Saccharomyces cerevisiae is photoreactivable but the fission
yeast Schizosaccharomyces pombe is not (2). Similarly,
primary fibroblasts from the rattlesnake (Crotalus horridus)
remove thymine dimers (TOT) by photoreactivation effi-
ciently, whereas those from the garter snake (Thamnophis
sp.) do not (3).
When mammalian cells were tested, initially it was claimed
that marsupials were capable ofphotoreversing YOY but that
placental animals, including humans, were not (4, 5). How-
ever, subsequent research on this subject yielded conflicting
results. In a series of papers, it was reported that human
leukocytes as well as human and murine cells in culture
contained photolyase (6-8), that fibroblasts from a patient of
xeroderma pigmentosum (XP) complementation group B
were completely defective in the enzyme (7), and that cell
lines from other XP complementation groups, including the
XP variant, had diminished photoreactivation activity (7, 8).
Other studies failed to detect photoreactivating enzyme
(DNA photolyase) in human or murine cell lines (9). How-
ever, evidence was presented suggesting that expression of
the enzyme is tissue-specific and that in tissue culture the
expression is influenced by the growth medium (10, 11),
which may account for the failure of some researchers to
detect photoreactivation in humans and other placental mam-
mals.
The presence or absence of photolyase in humans is
important from the standpoint of public health (12). There-
fore, we have reexamined this question, employing new
methodology that has become available within the last few
years-specifically, the ability to make large quantities of
substrate with a single TOT at a defined position (13). Such
a substrate makes it possible to detect very low levels of
photolyase. Further, since the photoproduct is chemically
incorporated into DNA the ambiguity arising from the nature
of the photoproduct affected by photoreactivation treatment
is eliminated. Our results with this substrate system and
extracts from cultured human cells and from white blood cells
(WBCs) taken from volunteers reveal that humans do not
have a photoreactivating enzyme.
MATERIALS AND METHODS
Materials. Mse I restriction endonuclease and polynucle-
otide kinase were from New England Biolabs. Poly(dA) and
(dT)12_18 were from Pharmacia. Sodium pyruvate and
3-NADH were from Sigma. [__32P]ATP (7000 Ci/mmol; 1 Ci
= 37 GBq) was from ICN. Purified E. coli DNA photolyase
was prepared as described (14).
Photolyase Substrates. Two types of substrates were used:
a synthetic oligomer with a single TOT, and UV-irradiated
pBR322. The synthetic substrate was prepared by the "build-
ing block" method (13) and was a gift of J.-S. Taylor and
D. L. Svoboda (Washington University, St. Louis). The
oligomer containing TOT was 20 nucleotides in length: 5'-
GCTCGAGCTATOTAACGTCAG-3'. To prepare substrate,
this 20-mer was 5'-end-labeled, annealed to the complemen-
tary strand, and digested with Mse I (which incises at
TITAA) to eliminate dimer-free contaminant. The resulting
DNA was >99% pure with regard to TOT content. The
concentration of the substrate used in Figs. 2 and 3 was
determined by Cerenkov counting and by taking into account
that 50%o of the label used in the kinase reaction was incor-
porated into DNA. The specific activity of this substrate was
6835 Ci/mmol.
The pBR322 substrate was prepared by irradiating the
plasmid with 254-nm light and the number of YOY per
plasmid molecule was determined by a transformation assay
(14).
Cell-Free Extracts (CFEs). Extracts were prepared from E.
coli (15) and S. cerevisiae (16) by established procedures.
Extract from rattlesnake (C. horridus) was prepared as
follows. Diamond-head rattlesnake muscle was obtained
from Aries (Dallas). The small pieces of frozen muscle
(typically 1-2 g) were homogenized in 10 vol of 50 mM
Tris-HCl, pH 7.5/100 mM NaCl/10 mM EDTA/10 mM
2-mercaptoethanol/0.25M sucrose/10mM leupeptin/10mM
aprotinin/10 mM phenylmethanesulfonyl fluoride. The de-
bris was removed by centrifugation at 32,000 x g for 20 min
and then at 120,000 x g for 2 hr. Proteins were precipitated
with 55% saturated ammonium sulfate, suspended in 50 mM
Abbreviations: CFE, cell-free extract; WBC, white blood cell; YOY,
pyrimidine dimer(s); TOT, thymine dimer(s); LDH, lactate dehy-
drogenase; Pol e, DNA polymerase E; XP, xeroderma pigmentosum.
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Tris-HCl, pH 7.4/10 mM EDTA/10 mM dithiothreitol/20o
(vol/vol) glycerol, and dialyzed against the same buffer with
50% glycerol. Aliquots of 200 Al were frozen in dry ice/
ethanol and stored at -70°C until use.
Human CFE was prepared from the HeLa cell line and
from WBCs. The preparation of whole CFE from HeLa cells
has been described (17-19). For small-scale preparations of
CFE from WBC, 35 ml of blood was withdrawn from each of
four workers in our laboratory. The WBCs were separated on
Ficoll-Paque R (Pharmacia LKB) gradients according to the
manufacturer's procedure. The milky buffy coat between the
plasma layer and the red blood cell layer was taken and CFE
was prepared as described (17-19). The yield of protein from
the WBCs of the four individuals ranged from 9.6 to 71.1 ,ug.
For large-scale preparation of human WBC extracts, 2 liters
of freshly drawn blood was obtained from the North Carolina
Red Cross Center and extract was prepared by the same
procedure. The yield was 27 mg at a concentration of 7.4
mg/ml. All CFEs were dialyzed against TDEG buffer (50mM
TrisHCl, pH 8.0/1 mM dithiothreitol/1 mM EDTA/17%
glycerol), aliquoted, frozen in dry ice/ethanol, and stored at
-80°C until use.
Often enzymes show suboptimal activity in CFE because
of interference by other proteins in the crude extract. There-
fore, we also partially purified the human CFE before testing
for activity. The concentrated CFE (10 mg at 14 mg/ml) was
loaded onto a 3-ml DEAE-agarose column equilibrated with
0.1 M NaCl in TDEG buffer. The column was washed with
the same buffer, which eluted about 80%o of the proteins
(fraction D1), and the bound proteins were eluted with 800
mM NaCl in the same buffer (fraction D2). D2 was dialyzed
into 0.1 M NaCl in TDEG and both Dl (7.2 mg/ml) and D2
(3.4 mg/ml) were stored in aliquots at -80°C until use.
Photolyase Assays. Two assays were employed, a chemi-
cal/coupled enzyme assay and a biological/transformation
assay. In the chemical assay, the reaction mixture (50 ,ul)
contained 50 mM Tris HCl (pH 7.5), 50 mM NaCl, 1 mM
EDTA, 20 mM dithiothreitol, 7% glycerol, 10 ,ug of bovine
serum albumin, 1.0 nM 20-mer (TOT), and the indicated
amounts of CFE. The reaction mixture (at 23°C) was exposed
to photoreactivating light from two Vivitar 5000 camera flash
units flashed 0-600 times at about 4-sec intervals simultane-
ously with illumination with a General Electric black light
(AX,k, 365 nm) at 2 mW/cm2 as indicated. Following photo-
reactivation, 1 ,ul of proteinase K (10 mg/ml) and 2.5 Al of
10% SDS were added and the samples were incubated for 30
min at room temperature. The DNA was then extracted with
phenol/chloroform, ethanol-precipitated, and suspended in
20 ,l4 of 10 mM Tris-HCl, pH 7.5/50 mM NaCl/10 mM
MgCl2/1 mM dithiothreitol. Two units of Mse I was added
and the mixture was incubated at 37°C for 1 hr. The digested
DNA was analyzed by electrophoresis in 12% polyacrylam-
ide sequencing gels. The gels were scanned with an Ambis
scanner (Ambis Systems, San Diego) to quantify the level of
repair, which is indicated by the fraction of 20-mer which is
converted to li-mer by restriction enzyme digestion.
Photoreactivation was also measured with natural DNA by
the transformation assay (14). The substrate was pBR322 (50
pg/ml) irradiated with 250 J/m2 of 254 nm from a General
Electric germicidal lamp. This irradiation produced 5.5 lethal
lesions per molecule. The photoreactivation assay was con-
ducted as follows. The reaction mixture (50 /) contained 50
mM Tris HCl (pH 7.4), 50 mM NaCl, 10 mM dithiothreitol,
0.15 pmol of pBR322 (0.83 pmol of UV photoproducts), and
20 ug ofCFE from E. coli, rattlesnake, or human WBCs. The
samples were photoreactivated at a fluence rate of 0.5
mW/cm2 for 0-70 min with a General Electric black light
(A,, 365 nm) filtered through an Oriel 290-nm-cutoff filter.
Following photoreactivation, the DNA was deproteinized
and suspended in 25 /ul ofwater. The level ofYOY repair was
tested by transformation (14).
Other Assays. The quality of animal CFEs was tested by
assaying for DNA polymerase e (Pol E) (20) and lactate
dehydrogenase (LDH) (21).
RESULTS
Test for Photolyase in CFEs from Various Species. Since
some enzymatic activities, particularly when present in low
levels, are obscured by other proteins present in CFEs, we
first wished to establish that photolyase can be detected in
CFEs from organisms known to have the enzyme at different
levels. E. coli contains 10-20 molecules of photolyase per
cell, and S. cerevisiae contains 100-200 molecules per cell
(2). As an animal control we used rattlesnake, which is known
to be efficient in photoreactivation (3). For humans, we used
leukocytes, since it has been reported that nonlymphocytic
WBCs are agood source ofthe enzyme (6, 7). However, it has
also been reported that as much as a 30-fold difference in
photolyase level can be found between individuals (22).
Therefore, we tested WBCs from four volunteers who were
chosen to represent different ethnic groups, as well as WBCs
from a blood bank.
CFEs from E. coli, yeast, and rattlesnake photorepaired
TOT efficiently (Fig. 1). The level of photoreactivation, when
compared with that achieved with pure E. coli photolyase,
and assuming similar catalytic efficiencies for the other
enzymes, is consistent with photolyase constituting about
10-6 to 10-5 of total cellular proteins in all three organisms.
In contrast to these species, CFEs from WBCs of four
individuals of Oriental (DH and YL), Croat/Irish (JR), and
Anglo-Saxon (TM) backgrounds failed to yield any detectable
FIG. 1. Repair ofTOT by CFEs from various species. CFEs were mixed with 20-mer (TOT) in 50 Al of reaction buffer and exposed to 200
camera flashes in '60 min while being exposed to a black light (A,, 365 nm) at 2 mW/cm2. After deproteinization the DNA was digested with
Mse I and separated in a 12% polyacrylamide gel. As a control the same assay was conducted with 0.27 ng of purified E. coli photolyase (PL).
CFE sources: EC, E. coli; SC, S. cerevisiae; CH, C. horridus; DH, YL, TM, and JR are the initials of the human donors of WBCs. Positions
of Mse I-resistant full-length substrate (20-mer) and the Mse I-generated 11-mer product from repaired DNA are indicated. The sample in lane
1 was exposed to 200 flashes and digested with Mse I, which yielded 0.2% 11-mer. This was taken as the background value in our calculations.
Source _ PL EC SC CH DH YL TM JR EC EC.JR
Protein (pg) 0 2.7x 10 42 44 6 19 4.8 4.5 13 4.2 4.2+13
% T<>T Repaired 0 27 13 23 16 0 0 0 0 3.6 2.3
Lane 1 2 3 4 5 6 7 8 9 10 11
20-mer * * * * i * * * *
| 11-mer |P ft_*
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photorepair. The lack ofrepair with human CFEs was not due
to the presence ofa specific photolyase inhibitor in the human
extracts. Mixing ofCFEs from human and E. coli resulted in
only partial inhibition of the E. coli enzyme (Fig. 1, lane 11),
as has been seen before with oligomer substrates (19, 23, 24).
In this assay we could easily have detected as little as 1%
repaired substrate, or about 4% of the repair we observed
with 2.7 x 10-4 ,ug of E. coli photolyase. Since human CFEs
ranging from 4.5 to 19 ,g failed to give a repair signal even
ofthis magnitude, ifhuman WBCs contain photolyase it must
constitute less than (2.7 x 10-4 x 4 x 10-2)/19 5 x 10-7
of total cellular proteins.
Effect of Protein Concentration. An in vitro system for
human nucleotide excision repair has been developed (17,
18). In this system it was found that for optimal activity the
CFE protein concentration was critical and needed to be
between 1 and 2 mg/ml (17). Considering the possibility that
there might be a similar concentration dependence for pho-
torepair, we conducted photoreactivation experiments with
various concentrations of CFEs from E. coli, rattlesnake
muscle, and human WBCs (Fig. 2). The level of photoreac-
A Lane 1 2 3 4 5 6
EC(pg) 5 5 10 20 50 100
* :I lIP * 0 4*- 20-mer
d_40_ _- 1 l-mer
CH(pg) 1 5 10 20 50 100
lb ;0.,,,.,f *i',,.,. -- * * 020-mer
*......
HS(pg) 1 22 52 104 208 560
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tivation increases linearly with the amount of rattlesnake
extract until the protein level becomes saturating, as is
expected for a bimolecular reaction. With E. coli CFE at high
protein concentrations some nonlinearity is observed due to
degradation ofDNA by nonspecific nucleases. Nevertheless,
at all concentrations tested photorepair is observed unam-
biguously. In contrast, no activity is detected with human
CFE in the range of 22-560 pg of protein. These data are
consistent with the conclusion that human WBCs do not
contain photolyase at a level exceeding 0-7 of total cellular
proteins.
Photoreactivation Kinetics. To further define the upper limit
of photolyase activity that might be present in human WBCs,
we conducted kinetic experiments. Fig. 3 shows that 49 ug of
E. coli extract and 6 ug of rattlesnake extract yielded similar
kinetics. With humanWBC extract, at 25 ,ug (data not shown)
and 50 ,ug per reaction no activity could be detected with up
to 600 camera flashes. Considering that E. coli, which con-
tains photolyase at a level of3 x 10-6 oftotal cellular proteins
(see Fig. 1), gave an easily detectable signal with 100 flashes
while human CFE failed to yield a signal (5% of the repair
seen with E. coli would have been detectable) even with 600
flashes, we conclude that the level of photolyase in human
CFE from WBC must be less than (3 x 10-6 x 5 x 10-2 x















FIG. 2. Repair ofTOT by E. coli (EC), rattlesnake (C. horridus,
CH), and human (Homo sapiens, HS) CFEs as a function of protein
concentration. The 50-,ul reaction mixtures contained 50 fmol of
substrate and the indicated -amounts of CFE protein and were
exposed to 200 flashes over a 60-min period as in Fig. 1. (A)
Autoradiograms of 12% polyacrylamide gels. Lanes 1, control reac-
tions in which samples containing the indicated amounts of protein
were kept in the dark and then treated with Mse I to determine the
basal level of li-mer, which was 0.8% for EC, 1% for CH, and 0.8%
for HS. These values have been subtracted from the values in lanes
2-6 to calculate the level of repair. (B) Average of data from two
experiments, including the one shown in A.
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FIG. 3. Repair of TOT by E. coli (EC), rattlesnake (CH), and
human (HS) extracts as a function of light dose. Reaction mixtures
containing 50 fmol of substrate and the indicated amounts ofCFE in
50 jA of reaction buffer were exposed to the indicated number of
camera flashes. TheDNA was then digested with Mse I and analyzed
by electrophoresis in 12% polyacrylamide gels, followed by autora-
diography. (A) Autoradiograms of gels. (B) Plot of repair kinetics
obtained from two experiments, including the one shown in A.
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Assay with Natural DNA. All of the experiments described
so far were carried out with the 20-mer TOT substrate.
However, a negative finding with this substrate may be due
to inability of a particular enzyme to bind to such a small
oligomer. To address this issue we tested the human, E. coli,
and rattlesnake CFEs by the transformation assay using
UV-irradiated pBR322. Again, efficient repair of DNA was
carried out by both E. coli and rattlesnake CFEs but none was
detectable with human WBC CFE (Fig. 4). The repair rate
with E. coli extract is consistent with the estimates ofenzyme
levels of 10 molecules per cell (2) or 5 x 10-6 of total cellular
proteins, which repair dimers at a rate of 5-6 TOT per min
per photolyase molecule (14) under the irradiation condition
used in Fig. 4. Again, a simple calculation reveals that if
humans have photolyase and if it has properties similar to all
other photolyases characterized to date, its level cannot be
more than 1 x 10-7 of total cellular proteins. Furthermore,
mixing ofhuman CFE with rattlesnake CFE did not affect the
rate of repair by rattlesnake photolyase, indicating that there
is no specific photolyase inhibitor in human CFE and that our
failure to detect photolyase in humans is most likely the result
of lack of photolyase in humans.
Quality ofExtracts. One possible explanation for our failure
to detect photolyase in human WBC was that the CFE made
from these cells was of poor quality in general and thus
defective not only in photolyase but in a host of other
enzymes. To address this possibility we tested CFEs from
HeLa cells, human WBCs, and rattlesnake muscle cells for a
housekeeping enzyme, LDH, and a nuclear enzyme, Pol E
(Table 1). All three cell extract types had comparable levels
ofLDH, and Pol e was abundant in actively replicating HeLa
cells but at very low (but detectable) levels in the mostly
quiescent WBCs and rattlesnake muscle cells. Photolyase
was detectable only in rattlesnake muscle cells. We consid-
ered the possibility that human WBC CFE might contain
inhibitory factors in the crude extract which interfere with
photolyase activity and therefore separated the CFE into a
low-salt (Dl) and a high-salt (D2) fraction by chromatography
on a DEAE resin. We failed to detect photolyase activity in
either fraction (Table 1).
600 _ /
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FIG. 4. Repair of YOY in pBR322 by CFEs from E. coli (X),
rattlesnake (o), rattlesnake muscle plus human WBCs (o), and
human WBCs (A). The 50 IL reaction mixtures contained 0.15 pmol
of pBR322 (0.8 pmol of lethal photoproducts) and 20 ,ug of CFE
protein. The rattlesnake CFE/human WBC CFE reaction mixtures
(0) contained 20 ,ug of each extract. After irradiation with a black
light (A4. 365 nm), the DNA was extracted with phenol/chloroform
and transformed into E. coli CSR603 to estimate the level of repair.
The values are averages from two experiments.




HeLa C. horridus CFE Dl D2
LDH* 109 400 231 ND ND
Pol et 14 5 x 10-3 2 x 10-2 ND ND
Photolyaset <0.3 36 <0.1 <0.2 <0.5
Dl and D2, DEAE low-salt and high-salt fractions, respectively;
ND, not determined.
*Unit definition according to ref. 21.
tUnit definition according ref. 20.
*One unit repairs 1 pmol in 1 hr (6). Values are from data in Fig. 4
for C. horridus and WBC CFE. The upper limits for human cells
were estimated as follows: 560 pg ofWBC CFE, 310 pg of Dl, 146
pg of D2, or 220 pg of HeLa CFE showed less than 1/10th the
activity of C. horridus CFE.
DISCUSSION
Since 1974 a number of reports on human photoreactivating
enzyme have been published. It is essential that we critically
evaluate some of the key papers and claims on this topic to
put the current work in context.
(i) Sutherland (6) reported the purification ofphotolyase to
apparent homogeneity in three steps. This protein of 40 kDa
was obtained at 24% recovery and had a specific activity of
6350 pmol mg-l hr-1. In terms of enzyme kinetics a photo-
lyase molecule with such a specific activity repairs 1 dimer in
4 hr under saturating light. Clearly, such an activity cannot be
of physiological significance, and we have been unable to
detect even such a low level when the TOT is measured
directly.
(ii) Several reports have been published claiming reduced
levels or total lack of photolyase activity in XP cell lines (7,
8, 25, 26). From the standpoint of this discussion the most
relevant is the paper which reported (7) the following residual
activities in XP cell lines (compared to 100%o in normal):
XP-A, 35.3%; XP-B, 0%6; XP-C, 15.8%; XP-D, 8%; XP-E,
49.5%. In recent years XP-A, -B, -C, and -D genes have been
cloned and sequenced and in the majority ofXP cell lines the
mutations inactivating the proteins have been identified and
are consistent with inactivation of a subunit of an excision
repair enzyme (27, 28). It is difficult to reconcile the reports
on defective photoreactivation in XP cells compared to
normal cells with the molecular genetics of XP.
(iii) Human photolyase reportedly has a nearly flat action
spectrum (range of activity within a factor of 3) in the 300- to
600-nm range (29-31). While such a finding in itself does not
cast doubt on the authenticity of the activity as that of a
photolyase, all known photolyases have well-defined action-
spectra peaks and none photoreactivates measurably at
wavelengths >500 nm (1, 24, 32, 33).
(iv) The first paper on photolyase from humans reported a
native molecular mass of 40 kDa for enzyme purified to
apparent homogeneity (6). More recently, by using an ul-
trafilter with a cutoffof 10 kDa, it was found that in all human
tissues examined there were at least two molecular species
with photolyase activity, one larger than 10 kDa, and one
smaller (34). All other photolyases that have been character-
ized to date have molecular masses of 50-60 kDa and are
made up of a single polypeptide with two noncovalently
bound chromophores (ref. 24; R. Ley, personal communica-
tion), and only a single type of enzyme has been found in
organisms ranging from E. coli to the marsupial Monodelphis
domestica (24, 33).
(v) The least ambiguous photolyase assay is the chemical
assay, which measures the YOY level directly by one of
several chromatographic procedures. This assay has been
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used in a few studies (6-8). Other studies have used the Norit
adsorption assay (34, 35), transformation competition assay
(36), and ESS (enzyme sensitive site) assay, which consists
of treatment of photoreactivated DNA with T4 endonuclease
V followed by separation in alkaline agarose gel (37) or
alkaline sucrose gradients (38). More recently immunological
methods using antibodies against UV-irradiated DNA (39) or
TOT (40) have been employed. While it is impossible to
critically evaluate all these studies here, the following facts
are worth mentioning. (a) d'Ambrosio et al. (38) report that
about 500,000 YOY are repaired by photoreactivation in 1
min in a single human skin cell as measured by the ESS assay.
It is impossible to reconcile this figure with the report that a
human photolyase molecule repairs 1 dimer every 4 hr under
conditions of saturating YOY substrate and light (6). In E.
coli and yeast (2, 24), in vivo and in vitro experiments yield
reasonably consistent results. (b) One of the most sensitive
assays for photolyase is the transformation assay. Harm (41)
easily detected photolyase in marsupial cell extract by this
assay but was unable to detect the activity with extract from
placental animals. (c) Eggset et al. (39) used antibodies made
against UV-irradiated DNA to measure photoreactivation of
YOY in human skin by employing immunohistochemical
methods and reported rapid disappearance of antigenic sites
when UV irradiation was followed by photoreactivation
treatment. However, upon further characterization the au-
thors found that the antigenic determinant for their antibodies
was probably the 6-4 photoproduct and not YOY.
(vi) It has been reported that in humans, when skin was
irradiated with a single UV (254 nm) dose followed by
exposure to photoreactivating light, no photoreactivation
could be observed; however, when the UV dose was split into
three parts administered at 2.5-hr intervals followed by
exposure to visible light after each irradiation, the level of
antigen reacting with a monoclonal antibody made against
TOT decreased by 40% (40). These results could be inter-
preted as induction of photolyase by sectored irradiation,
followed by splitting of TOT by the induced photolyase.
However, the authors caution that their assay is indirect and
does not necessarily mean that this treatment regimen re-
sulted in light-induced monomerization of YOY (42).
(vii) It was proposed that a protein which binds to UV-
irradiated DNA and is defective in the XP-E complementa-
tion group might be the human homolog of photolyase (43).
However, later studies revealed that this protein binds to 6-4
photoproducts and not to YOY (44) and therefore cannot be
a photolyase homolog.
In the present study we have used a defined substrate and
a direct assay for the enzymatic photoreversal of the cyclo-
butane ring to search for photolyase in human cells. We were
unable to detect activity in this system and found that the
absence of activity in CFE was not caused by an inhibitor
interfering with photolyase. We failed to detect any activity
in human WBCs with this assay, which can detect photolyase
at a level of 10-8 of total cellular proteins, or about 10
molecules per human cell. In summary, a critical evaluation
of papers on human photolyase and of data presented in this
paper leads us to conclude that it is most unlikely that humans
have a DNA photolyase. In agreement with other workers
(42, 45), we suggest that any future research on the subject
should be conducted with either defined substrate, pure
enzyme, or a cloned gene expressed in a heterologous
system.
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